| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.6 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |